Literature DB >> 11393667

Is C-reactive protein an independent risk factor for essential hypertension?

L E Bautista1, P López-Jaramillo, L M Vera, J P Casas, A P Otero, A I Guaracao.   

Abstract

CONTEXT: C-reactive protein (CRP), predicts coronary heart disease incidence in healthy subjects and has been associated with decreased endothelium-dependent relaxation, a potential risk factor for hypertension. However, the relationship between CRP and hypertension has not been studied.
OBJECTIVE: To assess whether circulating levels of CRP are independently related to essential hypertension.
DESIGN: Cross-sectional population survey. We measured circulating levels of CRP, blood pressure and cardiovascular risk factors among participants. Binomial regression was used to calculate the adjusted effect of CRP on the prevalence of hypertension.
SETTING: General community of Bucaramanga, Colombia. PARTICIPANTS: A random sample of 300 subjects > or = 30 years old. MAIN OUTCOME MEASURE: Arterial blood pressure.
RESULTS: Overall hypertension prevalence was 46.0%. The unadjusted prevalence of hypertension was 58.7% in the highest quartile of CRP, but only 34.7% in the lowest quartile. After adjustment for age, sex, body mass index, family history of hypertension, fasting glycemia, sedentary behaviour, and alcohol consumption, the prevalence of hypertension was 1.14 [95% confidence interval (CI), 0.82, 1.58; P= 0.442], 1.36 (95% CI, 0.99, 1.87; P= 0.057) and 1.56 (95% CI, 1.14, 2.13; P = 0.005) times higher in subjects in the second, third and fourth quartiles of CRP, as compared to subjects in the first quartile.
CONCLUSIONS: Our results suggest, for the first time, that CRP level may be an independent risk factor for the development of hypertension. However, because of the cross-sectional nature of our study, this finding should be confirmed in prospective cohort studies, aimed at elucidating the role of CRP in the prediction, diagnosis and management of hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11393667     DOI: 10.1097/00004872-200105000-00004

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  66 in total

1.  Coupling of Fcγ receptor I to Fcγ receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function.

Authors:  Nathan C Sundgren; Weifei Zhu; Ivan S Yuhanna; Ken L Chambliss; Mohamed Ahmed; Keiji Tanigaki; Michihisa Umetani; Chieko Mineo; Philip W Shaul
Journal:  Circ Res       Date:  2011-09-22       Impact factor: 17.367

Review 2.  Antihypertensive effects of aspirin: what is the evidence?

Authors:  Leonelo E Bautista; Lina M Vera
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

3.  Prehypertensive African-American women have preserved nitric oxide and renal function but high cardiovascular risk.

Authors:  Deborah L Feairheller; Kathleen M Sturgeon; Keith M Diaz; Praveen Veerabhadrappa; Sheara T Williamson; Deborah L Crabbe; Michael D Brown
Journal:  Kidney Blood Press Res       Date:  2010-07-13       Impact factor: 2.687

4.  The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study.

Authors:  G McGwin; T A Hall; A Xie; C Owsley
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

5.  Plasma adiponectin and insulin resistance in new onset hypertension.

Authors:  Teoman Dogru; Alper Sonmez; Ilker Tasci; M Ilker Yilmaz; Selim Kilic; Taner Ozgurtas; Tayfun Eyileten; M Kemal Erbil; I Hakki Kocar
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

6.  Relationship of high-sensitive C-reactive protein with cardiovascular risk factors, clinical presentation and angiographic profile in patients with acute coronary syndrome: an Indian perspective.

Authors:  Sharad Gupta; Vitull K Gupta; Rupika Gupta; Sonia Arora; Varun Gupta
Journal:  Indian Heart J       Date:  2013-05-16

Review 7.  Hypertension as an autoimmune and inflammatory disease.

Authors:  Yalcin Solak; Baris Afsar; Nosratola D Vaziri; Gamze Aslan; Can Ege Yalcin; Adrian Covic; Mehmet Kanbay
Journal:  Hypertens Res       Date:  2016-04-07       Impact factor: 3.872

Review 8.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

9.  Inflammation markers and risk of developing hypertension: a meta-analysis of cohort studies.

Authors:  Ahmad Jayedi; Kazem Rahimi; Leonelo E Bautista; Milad Nazarzadeh; Mahdieh Sadat Zargar; Sakineh Shab-Bidar
Journal:  Heart       Date:  2019-01-30       Impact factor: 5.994

10.  Blood Lead, Systemic Inflammation, and Blood Pressure: Exploring Associations and Mediation Effects in Workers Exposed to Lead.

Authors:  Haijiao Wang; Jixuan Ma; Ping He; Chengxin Yang; Dongkui He; Shiyu Zhao; Yujia Xie
Journal:  Biol Trace Elem Res       Date:  2020-09-21       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.